The effects of magnesium sulfate on placental vascular endothelial growth factor expression in preeclampsia

References

• WHO. World health report: make every mother and child count. Geneva: World Health Organization; 2005
   Google Scholar
• Bujold E, Romero R, Chaiworapongsa T, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med 2005;18:9–16
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27–31
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389–95
   PubMed Web of Science ®Google Scholar
• Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999;56:794–814
   PubMed Web of Science ®Google Scholar
• Baumgartner I, Isner JM. Somatic gene therapy in the cardiovascular system. Annu Rev Physiol 2001;63:427–50
   Google Scholar
• Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368–80
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997;99:2139–51
   PubMed Web of Science ®Google Scholar
• Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152–64
   PubMed Web of Science ®Google Scholar
• Skjaerven R,Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med 2002;346:33–8
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243–9
   PubMed Web of Science ®Google Scholar
• Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension 2004;44:72–7
   PubMed Web of Science ®Google Scholar
• Easterling TR. The maternal hemodynamics of preeclampsia. Clin Obstet Gynecol 1992;35:375–86
   Google Scholar
• Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005;46:1123–8
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Br Med J 2005;330:565
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Br J Obstet Gynecol 2003;110:831–6
   Google Scholar
• Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia--eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000;217:371–6
   PubMed Web of Science ®Google Scholar
• Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993;90:10705–9
   PubMed Web of Science ®Google Scholar
• Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004;95:884–91
   PubMed Web of Science ®Google Scholar
• Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990;162:1141–5
   PubMed Web of Science ®Google Scholar
• Hallak M, Berry SM, Madincea F, et al. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment. Obstet Gynecol 1993;81:185–8
   PubMed Web of Science ®Google Scholar
• Holcberg G, Sapir O, Hallak M, et al. Selective vasodilator effect of magnesium sulfate in human placenta. Am J Reprod Immunol 2004;51:192–7
   PubMed Web of Science ®Google Scholar
• Holcberg G, Amash A, Sapir O, et al. Different effects of magnesium sulfate and angiotensin II on the capacity of the fetal and maternal compartments of normal human placenta to secrete TNF-alpha and IL-6. J Reprod Immunol 2006;69:115–25
   PubMed Web of Science ®Google Scholar
• Amash A, Weintraub AY, Sheiner E, et al. Possible therapeutic effect of magnesium sulfate in pre-eclampsia by the down-regulation of placental tumor necrosis factor-alpha secretion. Eur Cytokine Netw 2010;21:58–64
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin Number 33, January 2002. ACOG Committee on Obstetric Practice. Int J Gynaecol Obstet 2002;77:67–75
   Google Scholar
• Schneider H, Huch A. Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib Gynecol Obstet 1985;13:40–7
   PubMedGoogle Scholar
• Holcberg G, Amash A, Sapir O, et al. Different effects of magnesium sulfate and angiotensin II on the capacity of the fetal and maternal compartments of normal human placenta to secrete TNF-a and IL-6. J Reprod Immunol 2006;69:115–25
   PubMed Web of Science ®Google Scholar
• Sgambati E, Marini M, Zappoli Thyrion GD, et al. VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 2004;111:564–70
   PubMed Web of Science ®Google Scholar
• Torry DS, Torry RJ. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol 1997;37:21–9
   PubMed Web of Science ®Google Scholar
• Shore VH, Wang TH, Wang CL, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997;18:657–65
   PubMed Web of Science ®Google Scholar
• Bosio PM, Wheeler T, Anthony F, et al. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 2001;184:146–52
   PubMed Web of Science ®Google Scholar
• Hunter A, Aitkenhead M, Caldwell C, et al. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 2000;36:965–9
   PubMed Web of Science ®Google Scholar
• VanWijk MJ, Kublickiene K, Boer K, VanBavel E. Vascular function in preeclampsia. Cardiovasc Res 2000;47:38–48
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Daniel Y, Englender T, et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol 1997;38:302–6
   PubMed Web of Science ®Google Scholar
• Lyall F, Young A, Boswell F, et al. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997;18:269–76
   PubMed Web of Science ®Google Scholar
• Simmons LA, Hennessy A, Gillin AG, Jeremy RW. Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy. Br J Obstet Gynecol 2000;107:678–85
   Google Scholar
• Cooper JC, Sharkey AM, Charnock-Jones DS, et al. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996;103:1191–6
   PubMedGoogle Scholar
• Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998;92:883–9
   PubMed Web of Science ®Google Scholar
• Vadnais MA, Rana S, Quant HS, et al. The impact of magnesium sulfate therapy on angiogenic factors in preeclampsia. Pregnancy Hypertens 2012;2:16–21
   PubMedGoogle Scholar
• Kułak W, Okurowska-Zawada B, Sienkiewicz D, et al. Risk factors for cerebral palsy in term birth infants. Adv Med Sci 2010;55:216–21
   Google Scholar
• Mann JR, McDermott S, Griffith MI, et al. Uncovering the complex relationship between pre-eclampsia, preterm birth and cerebral palsy. Paediatr Perinat Epidemiol 2011;25:100–10
   Google Scholar